Platelet–leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential
Cardiovascular Research · 29.09.2025 · 121 (11) · 1679-1696
DOI: 10.1093/cvr/cvaf105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 09.06.2025. Verfasst von Jiaying Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Blood Platelets, Cardiovascular Diseases, Leukocytes, Platelet Aggregation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 165 Literaturangaben.
Abstract (Originalsprache)
Initially recognized for their role in vascular haemostasis, platelets are now understood to be critical regulators of inflammation and immune responses through complex interactions with immune cells. Key to this role is the formation of platelet–leukocyte aggregates (PLAs), with platelet–monocyte aggregates (PMAs) representing the most thoroughly studied type in cardiovascular disease. PLAs form through the binding of platelet surface P-selectin to P-selectin glycoprotein ligand on leukocytes, an early interaction that may trigger broader inflammatory cascades. Recent studies link circulating PMAs with in vivo platelet activation and elevated PMA levels in patients with high thrombogenic risk, such as those with diabetes and acute myocardial infarction. Furthermore, PMA levels correlate with disease severity and long-term cardiovascular outcomes, highlighting their potential as prognostic biomarkers for adverse cardiovascular events. Therapeutic strategies, such as antiplatelet agents and P-selectin antagonists, have demonstrated efficacy in the inhibition of PLA formation. However, the development of selective inhibitors that preserve the haemostatic and immune functions of platelets remains an unmet clinical need. Despite significant progress, the precise biological functions and underlying mechanisms of PLAs are not fully understood. This review integrates preclinical and clinical data to provide a comprehensive overview of platelet–leukocyte biology, with a focus on the prognostic role and therapeutic potential of PLAs in cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
- Department of Internal Medicine I, University Hospital Augsburg, University of Augsburg, Augsburg, Germany.
- Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.
- Department of Cardiovascular Medicine, Humanitas Clinical and Research Center IRCCS, Humanitas University, Rozzano, Milan, Italy.
ORCID-Profile: Jiaying Han, Conor J Bloxham, Kilian Kirmes, Leonhard P Unkelbach, Moritz von Scheidt, Stephanie G Kühne, Isabell Bernlochner, Gianluigi Condorelli, Philip W J Raake, Dario Bongiovanni
Zitieren
APA
Han, J., Bloxham, C. J., Kirmes, K., Viggiani, G., Unkelbach, L. P., von Scheidt, M., Kühne, S. G., Bernlochner, I., Condorelli, G., Raake, P. W. J., & Bongiovanni, D. (2025). Platelet–leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential. Cardiovascular Research, 121(11), 1679-1696. https://doi.org/10.1093/cvr/cvaf105
Vancouver
Han J, Bloxham CJ, Kirmes K, Viggiani G, Unkelbach LP, von Scheidt M, et al. Platelet–leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential. Cardiovascular Research. 2025;121(11):1679-1696. doi:10.1093/cvr/cvaf105
BibTeX
@article{Han2025,
author = {Han, Jiaying and Bloxham, Conor J and Kirmes, Kilian and Viggiani, Giacomo and Unkelbach, Leonhard P and von Scheidt, Moritz and Kühne, Stephanie G and Bernlochner, Isabell and Condorelli, Gianluigi and Raake, Philip W J and Bongiovanni, Dario},
title = {Platelet–leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {11},
pages = {1679--1696},
doi = {10.1093/cvr/cvaf105}
}
EUVIMED